Stimulant Use Disorder Clinical Trials

8 recruitingLast updated: June 18, 2026

There are 8 actively recruiting stimulant use disorder clinical trials across 2 countries. Studies span Not Applicable, Phase 2, Phase 1. Top locations include Atlanta, Georgia, United States, Baltimore, Maryland, United States, Boston, Massachusetts, United States. Updated daily from ClinicalTrials.gov.


Stimulant Use Disorder Trials at a Glance

8 actively recruiting trials for stimulant use disorder are listed on ClinicalTrialsFinder across 6 cities in 2 countries. The largest study group is Not Applicable with 5 trials, with the heaviest enrollment activity in Atlanta, Baltimore, and Boston. Lead sponsors running stimulant use disorder studies include Elana Rosenthal, Korea University Anam Hospital, and DynamiCare Health.

Browse stimulant use disorder trials by phase

Treatments under study

About Stimulant Use Disorder Clinical Trials

Looking for clinical trials for Stimulant Use Disorder? There are currently 8 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Stimulant Use Disorder trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Stimulant Use Disorder clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting
Not Applicable

reSET for the Treatment of Stimulant Use in HIV Clinics: Care Optimization Supporting Treatment Adherence (COSTA)

People Living With HIVStimulant Use Disorder
University of Miami260 enrolled1 locationNCT05958017
Recruiting
Not Applicable

RESTORE Study R61 Phase: Recovery and Engagement for Stimulant Users on Re-entry

HIVHIV PreventionJustice Involved Populations+1 more
University of Texas Southwestern Medical Center40 enrolled2 locationsNCT07136363
Recruiting
Phase 1

Optimizing Transcranial Magnetic Stimulation for Stimulant Use Disorder

Stimulant Use Disorder
University of Minnesota50 enrolled1 locationNCT06790576
Recruiting
Not Applicable

Continuum of Care in Hospitalized Patients With Opioid/Stimulant Use Disorder and Infectious Complications From Drug Use

Opioid-use DisorderStimulant Use DisorderInjection Related Infections
Elana Rosenthal304 enrolled4 locationsNCT06513156
Recruiting
Phase 2

Orexin Receptor Antagonism and Sleep in Stimulant Use Disorder

Stimulant Use Disorder
The University of Texas Health Science Center, Houston20 enrolled1 locationNCT06444256
Recruiting
Not Applicable

A Clinical Trial to Evaluate the Safety and Efficacy of Neuromodulation Using 'ExAblate 4000 Type 2.1' in Patients With Psychostimulant Use Disorder(PUD)

Psychostimulant Use Disorder(PUD)
Korea University Anam Hospital10 enrolled1 locationNCT06474026
Recruiting
Not Applicable

Smartphone Services for Stimulant Use Disorder

Stimulant Use Disorder
DynamiCare Health270 enrolled1 locationNCT07092059
Recruiting
Phase 2

Mirtazapine for the Treatment of Methamphetamine Use in Opioid Use Disorder Patients Receiving Medication Assisted Treatment

Stimulant Use Disorder
Washington State University60 enrolled1 locationNCT06323837